Brief: Solid Biosciences Inc Expects To Report Cash And Investments Of About $214 Mln As Of December 31, 2022
Jan 9 (Reuters) - Solid Biosciences Inc SLDB.O :
* SOLID BIOSCIENCES INC - EXPECTS TO REPORT CASH AND
INVESTMENTS
OF ABOUT $214 MILLION AS OF DECEMBER 31, 2022
Source text for Eikon: ID:
Further company coverage: SLDB.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Solid Biosciences
See all newsSolid Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Solid Biosciences Inc expected to post a loss of 48 cents a share - Earnings Preview
Solid Biosciences Q2 net loss widens on higher R&D costs
Marketing Agreement To Advance Gene Therapy Delivery And Analytics
Solid Biosciences Q1 net loss widens on higher R&D costs